Full Press Release Details
QUIPT HOME MEDICAL ANNOUNCES VOTING RESULTS
FROM ITS ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
Cincinnati, Ohio - March 28, 2024 -
Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT) , a U.S. based home medical equipment provider,
focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders
held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or
by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company.
Election of Directors
The four candidates nominated for election to
the Company's Board of Directors (the "Board") and listed in the Company's management information and proxy
circular dated February 14, 2024 (the "Circular"), were elected by at least a majority of the shareholders present
in person or represented by proxy at the Meeting. The voting results are as follows:
| Name | Votes For | % For | Votes Withheld | % Withheld | ||||
| Gregory Crawford | 17,767,804 | 77.74% | 5,088,933 | 22.26% | ||||
| Mark Greenberg | 17,425,384 | 76.24% | 5,431,353 | 23.76% | ||||
| Kevin Carter | 20,217,074 | 88.45% | 2,639,663 | 11.55% | ||||
| Brian Wessel | 20,239,145 | 88.55% | 2,617,592 | 11.45% |
Appointment of Auditors
The Company's shareholders have approved
the re-appointment of BDO USA, P.C. as the auditor of the Company for the fiscal year ended December 31, 2024 and authorized the
Board to fix the auditor's remuneration.
Approval of the 2024 Equity Incentive Plan
The Company's shareholders have approved
the 2024 Equity Incentive Plan of the Company (the "Incentive Plan"), pursuant to which the Company is able to
issue share-based long-term incentives. All directors, officers, employees and service providers of the Company and/or its affiliates
are eligible to receive awards under the Incentive Plan, subject to the terms of the Incentive Plan. Awards include common
share purchase options, stock appreciation rights, restricted share awards, restricted share bonuses, restricted share units, performance
shares, performance units, cash-based awards, and other share-based awards under the Incentive Plan. A copy of the Incentive
Plan is attached as Schedule "A" to the Circular. As a result of the adoption of the Incentive Plan, no future awards
or grants will be made under the Company's current equity incentive plan, which became effective on May 3, 2021.
report of voting results describing each of the matters voted upon at the Meeting has been filed on SEDAR+ under the Company's
issuer profile at www.sedarplus.ca.
ABOUT QUIPT HOME MEDICAL CORP.
The Company provides in-home monitoring and disease
management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue
to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary
disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is
to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease
management. The Company's organic growth strategy is to increase annual revenue per patient by offering multiple services to
the same patient, consolidating the patient's services and making life easier for the patient.
further information please visit our website at www.quipthomemedical.com, or contact:
VP of Corporate Development
Quipt Home Medical Corp.
Chief Executive Officer
Quipt Home Medical Corp.